Histamine H3 receptor: a potential drug target for the treatment of central nervous system disorders
LF Alguacil - Current Drug Targets-CNS & Neurological …, 2003 - ingentaconnect.com
Histamine H3 receptors were first described in the eighties but finally cloned four years ago.
They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
Histamine H3 receptor: a potential drug target for the treatment of central nervous system disorders
LF Alguacil, C Pérez-García - Current drug targets. CNS …, 2003 - pubmed.ncbi.nlm.nih.gov
Histamine H (3) receptors were first described in the eighties but finally cloned four years
ago. They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
ago. They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
[PDF][PDF] Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders
LF Alguacil, C Pérez-García - Current Drug Targets-CNS & …, 2003 - researchgate.net
Histamine H3 receptors were first described in the eighties but finally cloned four years ago.
They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
Histamine H3 receptor: a potential drug target for the treatment of central nervous system disorders.
LF Alguacil, C Pérez-García - Current Drug targets. CNS and …, 2003 - europepmc.org
Histamine H (3) receptors were first described in the eighties but finally cloned four years
ago. They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
ago. They are G-protein coupled, mostly presynaptic, and are involved in the control of the …